Results 21 to 30 of about 353,788 (280)
Neurology, 2016 For many years, there has been a debate between “brand name” and “generic” medications.1,2 When a person has an occasional headache and takes acetaminophen to relieve the pain, he or she may have the same relief as if he or she had taken the brand name, Tylenol. However, what if the illness is chronic? Now suppose the illness is something more serious,
openaire +2 more sources
Seizures and epilepsy in patients with ischaemic stroke
Neurological Research and Practice, 2021 Background With the increased efficacy of stroke treatments, diagnosis and specific treatment needs of patients with post-stroke seizures (PSS) and post-stroke epilepsy have become increasingly important.
Johann Philipp Zöllner +6 more
doaj +1 more source
Antiseizure medication discovery: Recent and future paradigm shifts
Epilepsia Open, 2022 Despite the ever‐increasing number of available options for the treatment of epilepsies and the remarkable advances on the understanding of their pathophysiology, the proportion of refractory patients has remained approximately unmodified during the last
Alan Talevi
doaj +1 more source
Medication taking behaviour and hypertension: A review of the literature [PDF]
, 2009 Hypertension is a global illness and one that affects circa 20% of the population. Despite the effectiveness of treatment, adherence with medication is a key concern, particularly in the elderly.
Banning, M
core +6 more sources
Epilepsia Open, 2022 Objective The prevalence of epilepsy is slightly higher in women than in men and sensitivity to seizure stimuli differs between sexes. Some evidence suggests sex differences in response to antiseizure medications exist mainly due to inconsistent ...
M. Soledad Cepeda +3 more
doaj +1 more source
Drug‐resistant epilepsy: Drug target hypothesis and beyond the receptors
Epilepsia Open, 2022 Epilepsy is a chronic neurological disorder that affects more than 50 million people worldwide. Despite a recent introduction of antiseizure drugs for the treatment of epileptic seizures, one‐third of these patients suffer from drug‐resistant epilepsy ...
Daniel Fonseca‐Barriendos +5 more
doaj +1 more source
Neurobiology of Disease, 2023 Intracerebral drug delivery is an experimental approach for the treatment of drug-resistant epilepsies that allows for pharmacological intervention in targeted brain regions.
Devlin MacKeigan +7 more
doaj +1 more source
Identification of New Antiseizure Medication Candidates in Preclinical Animal Studies
, 2023 Epilepsy is a multifactorial neurologic disease that often leads to many devastating disabilities and an enormous burden on the healthcare system. Until now, drug-resistant epilepsy has presented a major challenge for approximately 30% of the epileptic ...
Sheng-Nan Wu +4 more
core +1 more source
Anti-seizure medication treatment trials prior to pre-surgical evaluation
Epilepsy & Behavior Reports, 2022 Purpose: Our study evaluates patterns of anti-seizure medication (ASM) usage prior to pre-surgical evaluation in drug resistant epilepsy (DRE). Methods: We conducted a retrospective study of patients with DRE presenting for pre-surgical evaluation from 1/
Vishal Pandya +5 more
doaj +1 more source
Are attitudes towards medication adherence associated with medication adherence behaviours among patients with psychosis? A systematic review and meta analysis [PDF]
, 2013 Background Studies have shown patient attitudes to be an important predictor for health related behaviours including medication adherence. It is less clear whether patient attitudes are also associated with medication adherence among patients with ...
McCabe, R. +5 more
core +1 more source